IPO for Cell-Engineering Firm MaxCyte (MXCT) Opens 31% Higher Jul 30, 2021 12:19PM
MaxCyte, Inc. (MXCT) Prices Upsized 13.5M Share Nasdaq IPO at $13/sh Jul 30, 2021 05:26AM
MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market Jul 29, 2021 10:42PM
MaxCyte, Inc (MXCT) Announced 12M Share IPO at $11.50-$13.50 Jul 26, 2021 07:50AM
MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market Jul 26, 2021 07:49AM


Jul 12, 2021 02:00AM MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing